Advertisement
AIM 外匯新聞
AIM ImmunoTech Inks Pancreatic Cancer Clinical Research Deals With AstraZeneca, Erasmus
Immuno-pharma company AIM ImmunoTech Inc. (AIM) announced Tuesday it has entered into an external sponsored collaborative clinical research agreement with Netherland-based Erasmus University Medical Center and AstraZeneca plc. (AZN, AZN.L).
RTTNews
|
832天前
